Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter To Editor
2005:71:5;363-364
doi: 10.4103/0378-6323.16795
PMID: 16394469

Preventing strongyloidiasis in the immunosuppressed

P Narasimha Rao, KU Kiran
 Hyderabad, India

Correspondence Address:
P Narasimha Rao
B-48, I.T. Colony, Mehdipatnam, Hyderabad - 500 028
India
How to cite this article:
Rao P N, Kiran K U. Preventing strongyloidiasis in the immunosuppressed. Indian J Dermatol Venereol Leprol 2005;71:363-364
Copyright: (C)2005 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

We are writing this letter in response to the case report "Fatal disseminated strongyloidiasis in patients on immunosuppressive therapy: report of two cases" published in the IJDVL of Jan-Feb 2005.[1] We congratulate the authors for this report.

Recently, there was another report of death due to strongyloidiasis hyperinfection in a leprosy patient on treatment with corticosteroids for a type II lepra reaction.[2] These articles highlight the importance of remembering common as well as often neglected infestations that can potentially cause morbidity and mortality in patients of dermatological disorders and in organ transplant recipients on immunosuppressive therapy.

Strongyloidiasis is endemic in tropical and subtropical countries. It is estimated to affect more than 70 million people worldwide. Its prevalence rates are as high as 40% in certain areas, especially West Africa, the Caribbean, and Southeast Asia, including India. Hence, although strongyloidiasis is not given much importance in India, the search for strongyloidiasis in patients with predisposing factors is important. These predisposing factors include any cause of immunosuppression, e.g. use of immunosuppressive agents, malignancy, HIV infection, collagen vascular disease, diabetes mellitus, malnutrition, and advanced age. In patients who were exposed to the parasite, the likelihood of strongyloidiasis should be carefully assessed before immunosuppressive therapy is started.[3] In a case-control study, corticosteroid users were shown to have 3.3 times greater risk of developing strongyloidiasis.[4] Hyperinfection with strongyloidiasis has a high mortality rate (up to 80%) because the diagnosis is often delayed due to the nonspecific presentation in a patient who is immunocompromised. Most immunocompetent patients have asymptomatic chronic infections causing negligible morbidity.[5]

That strongyloidiasis should be excluded before initiating immunosuppressive therapy is widely known. In Indian leprosy manuals, strongyloidiasis is mentioned as a contraindication for steroid therapy in patients of leprosy. However, the fact that strongyloidiasis should be treated before initiating steroid therapy is not emphasized. In Cambodia, where strongyloidiasis is rife, its national leprosy progamme is considering the inclusion of albendazole in the pre-packed steroid blister packs as it is considered cost effective to treat strongyloidiasis than to screen all leprosy patients for it.[2]

Similarly, the logic of treating patients empirically with albendazole or ivermectin for strongyloidiasis also holds good for other dermatological diseases where long term immunosuppressive therapy is indicated. The recommended dose of albendazole for intestinal strongyloidiasis is 400 mg orally twice daily for 5 days. Ivermectin is the drug of choice for the treatment of strongyloidiasis in the WHO′s list of essential drugs, the dose for intestinal infection being 200 mcg/kg per day as a single dose.[6] A single dose of ivermectin produced 94% cure rates in intestinal strongyloidiasis.[7] In strongyloidiasis hyperinfection, although the efficacy of ivermectin is yet to be established, the dose should be repeated on days 2, 15 and 16; it may be necessary to prolong treatment with ivermectin or change to thiabendazole (5 to 7 days or longer).

Strongyloidiasis hyperinfection is rarely reported in leprosy, but this may be due to under-reporting as the diagnosis could be missed.[2] Similarly it may be underreported in patients on immunosuppressive drugs as it can manifest with central nervous system, hematological, gastrointestinal, respiratory or cutaneous involvement. The search and treatment of strongyloidiasis should be made a part of the routine protocol in all immunosuppressed patients and in those in whom immunosuppressive therapy is to be initiated. Such a protocol would prevent the potentially fatal complications of hyperinfection due to an otherwise benign nematode.

References
1.
Reddy IS, Swarnalata G. Fatal disseminated strongyloidiasis in patients on immunosuppressive therapy: Report of two cases. Indian J Dermatol Venereol Leprol 2005;71:38-40.
[Google Scholar]
2.
Leang B, Lynen L, Tootill R, Griffiths A, Monchy D. Death caused by strongyloidiasis hyperinfection in a leprosy patient on treatment for type II leprosy reaction. Lepr Rev 2004;75:398-403.
[Google Scholar]
3.
Tarlow MM, Schwartz RA. Strongyloidiasis. http://www. emedicine.com/derm/topic838.h Last accessed: 15.3.2004
[Google Scholar]
4.
Davidson RA, Fletcher RH, Chapman LE. Risk factors for strongyloidiasis, a case control study. Arch Intern Med 1984;144:321-4.
[Google Scholar]
5.
Polenakovik H, Polenakovik S. Strongyloidiasis. http://www. emedicine.com/derm/topic838. h last accessed: 15.3.2004.
[Google Scholar]
6.
Siddiqui AA Berk SI. Diagnosis of Strongyloidiasis stercoralis infection. Clin Infect Dis 2001;33:1040-7.
[Google Scholar]
7.
Naquira C, Jimenez G, Guerra JG, Bernal R, Nalin DR, Neu D, et al . Ivermectin for human strongyloidiasis and other intestinal infections. Am J Trop Med Hyg 1989;40:304-9.
[Google Scholar]

Fulltext Views
1,035

PDF downloads
732
Show Sections